 Home > Medical News > Latest Medical News > $470.5 million!

$470.5 million!

 Last Update: 2021-04-19
 Source: Internet
 Author: User

Tags

lexapro mechanism action

caco 2 cells

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 30, ImmuneOncia Therapeutics and 3D Medicines signed an exclusive license agreement for the anti-CD47 monoclonal antibody IMC-002.

According to the terms of the agreement, ImmuneOncia will receive an advance payment of US$8 million from Sidi Medicine.

IMC-002 is a fully human IgG4 monoclonal antibody designed to block the CD47-SIRPα interaction to promote the phagocytosis of cancer cells by macrophages.

Prior to this, in September last year, AbbVie received nearly US$2 billion in CD47 antibody development rights from Tianjing Biosciences; in March last year, Gilead purchased US$4.

▲The mechanism of action of anti-CD47 antibody (picture source: "Nature Biomedical Engineering")

Reference materials:

[1] ImmuneOncia and 3D Medicines Signed Exclusive License Agreement to Develop, Manufacture and Commercialize IMC-002 in Greater China.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.